DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Bear HD, Tang G, Rastogi P. et al.
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
Lancet Oncol 2015;
16: 1037-1048
We do not assume any responsibility for the contents of the web pages of other providers.